ReAlta Life Sciences, Inc. ("ReAlta" or the "Company"), a clinical-stage biopharmaceutical company dedicated to saving lives by rebalancing the inflammatory response to address rare and acute ...

November 4, 2024Krystal Biotech, Inc. beats earnings expectations. Reported EPS is $0.909, expectations were $0.9. Operator: Thank you for standing by and welcome to Krystal Biotech's Third Quarter ...

Q3 2024 Earnings Conference Call November 4, 2024 8:30 AM ET. Company Participants. Stéphane Paquette - VP, Corporate Development Krish Krishn ...

With average prices above those of Zara, H&M, and Primark, Asos operates in the midmarket segment, which has been underperforming in recent years, as it lacks the value proposition of low-cost peers ...

with efficient editing and very low off-target activities, which was also published in Nature Biotechnology 2022, laying out the technical foundation of the CRISPR/Cas13 system for future clinical ...

Seven participants across two cohorts dosed in the Heart-2 Phase 1b clinical trial of VERVE-102 targeting PCSK9; Initial data planned for the ...

( MENAFN - The Conversation) Elon Musk is supporting Donald trump in his quest to regain the American presidency. He has ...

( MENAFN - UkrinForm) Ukraine's Defense Minister Rustem Umerov has called on veterans, who now number nearly one million, to ...

Thank you for standing by and welcome to Krystal Biotech's third-quarter earnings conference call. (Operator Instructions) As a reminder, today's conference is being recorded. I would now like to hand ...